Relation of Death Within 90 Days of Non-ST-Elevation Acute Coronary Syndromes to Variability in Electrocardiographic Morphology
To access this article, please choose from the options below
This work was supported, in part, by Center for Integration of Medicine and Innovative Technology, Harvard-MIT Division of Health Sciences and Technology, and Industrial Technology Research Institute (Taiwan). The DISPERSE2 trial was supported by AstraZeneca.
PII: S0002-9149(08)01676-7
doi:10.1016/j.amjcard.2008.09.099
© 2009 Elsevier Inc. All rights reserved.
